These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16553527)

  • 1. Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.
    Mosholder AD; Pamer CA
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):33-6. PubMed ID: 16553527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis.
    Mosholder AD; Willy M
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):25-32. PubMed ID: 16553526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.
    Posner K; Oquendo MA; Gould M; Stanley B; Davies M
    Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of benzonatate overdoses among adults and children from 1969-2010 by the United States Food and Drug Administration.
    McLawhorn MW; Goulding MR; Gill RK; Michele TM
    Pharmacotherapy; 2013 Jan; 33(1):38-43. PubMed ID: 23307543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New thoughts on the "forgotten" aspect of antimicrobial stewardship: adverse event reporting.
    Hoffmann C; Khadem T; Schweighardt A; Brown J
    Pharmacotherapy; 2015 Jan; 35(1):59-63. PubMed ID: 25615401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
    Sonawane KB; Cheng N; Hansen RA
    J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration.
    Hartnell NR; Wilson JP
    Pharmacotherapy; 2004 Jun; 24(6):743-9. PubMed ID: 15222664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of databases in drug postmarketing surveillance.
    Rodriguez EM; Staffa JA; Graham DJ
    Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.
    Stübner S; Grohmann R; Greil W; Zhang X; Müller-Oerlinghausen B; Bleich S; Rüther E; Möller HJ; Engel R; Falkai P; Toto S; Kasper S; Neyazi A
    Int J Neuropsychopharmacol; 2018 Sep; 21(9):814-821. PubMed ID: 29939264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
    Johann-Liang R; Wyeth J; Chen M; Cope JU
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacovigilance of new antidepressants: evaluation of neuro-psychobehavioral disorders].
    Blayac JP; Hillaire-Buys D; Peyrière H
    Therapie; 1997; 52(2):117-22. PubMed ID: 9231505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
    Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT
    Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.
    Apter A; Lipschitz A; Fong R; Carpenter DJ; Krulewicz S; Davies JT; Wilkinson C; Perera P; Metz A
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):77-90. PubMed ID: 16553530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of adverse behavioral effects with pediatric use of antidepressants.
    Goodman WK; Murphy TK; Storch EA
    Psychopharmacology (Berl); 2007 Mar; 191(1):87-96. PubMed ID: 17180618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.